Recursion Pharmaceuticals, Inc. RXRX Professional service fees
Professional service fees at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s professional service fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s professional service fees?
- Recursion Pharmaceuticals, Inc. (RXRX) reported professional service fees of $1.88M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s professional service fees changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s professional service fees decreased by 34.3% year-over-year, from $2.86M to $1.88M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s professional service fees?
- Over 4 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s professional service fees has grown at a 233.2% compound annual growth rate (CAGR), from $10K to $1.23M.